Roche’s alzheimer’s drug clears plaques in 28 weeks, faces 2028 test to slow memory loss

3 weeks ago 46

Roche’s experimental Alzheimer’s drug, trontinemab, has cleared harmful macromolecule deposits from the brains of 9 retired of 10 patients within